The NAME trial: a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer

Autor: Langkjer, Sven Tyge, Kenholm, Julia, Jensen, Jeanette Dupont, Wedervang, Kim, Torbøl Brixen, Annette, Grunnet, Mie, Stenbygaard, Lars, Gilje, Bjørnar, Danø, Hella, Glavicic, Vesna, Hugger Jacobsen, Erik, Brems-Eskildsen, Anne Sofie, Lemvig Kruse, Helle, Dongsgaard, Trine, Neimann, Jeppe, Geisler, Jürgen

Publikováno v: Langkjer, Sven Tyge Kenholm, Julia Jensen, Jeanette Dupont Wedervang, Kim Torbøl Brixen, Annette Grunnet, Mie Stenbygaard, Lars Gilje, Bjørnar Danø, Hella Glavicic, Vesna Hugger Jacobsen, Erik Brems-Eskildsen, Anne Sofie Lemvig Kruse, Helle Dongsgaard, Trine Neimann, Jeppe Geisler, Jürgen . The NAME trial: a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer. Future Oncology. 2019, 15(22), 2561-2569
Future Oncology

Externí odkaz: http://hdl.handle.net/10852/77735
https://www.duo.uio.no/bitstream/handle/10852/77735/2/fon-2019-0124.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.

Autor: Langkjer ST; Department of Oncology, Aarhus University Hospital, 8200 Aarhus C, Denmark., Kenholm J; Department of Oncology, Regionshospitalet Herning, 7400 Herning, Denmark., Jensen JD; Department of Oncology, Odense University Hospital, 5000 Odense, Denmark., Wedervang K; Department of Oncology, Sønderborg Sygehus, 6400 Sønderborg, Denmark., Brixen AT; Department of Oncology, Herlev Hospital, 2730 Herlev, Denmark., Grunnet M; Department of Oncology, Rigshospitalet, 2100 Copenhagen, Denmark., Stenbygaard L; Department of Oncology, Aalborg Sygehus Syd, 9100 Aalborg, Denmark., Gilje B; Department of Hematology & Oncology, Stavanger University Hospital, 4011 Stavanger, Norway., Danø H; Department of Oncology, Hilleroed Hospital, 3400 Hilleroed, Denmark., Glavicic V; Department of Oncology, Naestved, 4700 Naestved, Denmark., Jacobsen EH; Department of Oncology, Sydvestjysk Sygehus Esbjerg, 6700 Esbjerg, Denmark., Brems-Eskildsen AS; Department of Oncology, Aarhus University Hospital, 8200 Aarhus C, Denmark., Kruse HL; Department of Oncology, Aarhus University Hospital, 8200 Aarhus C, Denmark., Dongsgaard T; Department of Oncology, Regionshospitalet Herning, 7400 Herning, Denmark., Neimann J; Department of Oncology, Aarhus University Hospital, 8200 Aarhus C, Denmark., Geisler J; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.

Publikováno v: Future oncology (London, England) [Future Oncol] 2019 Aug; Vol. 15 (22), pp. 2561-2569. Date of Electronic Publication: 2019 Jun 19.